# FINAL_FORENSIC_AUDIT_SUMMARY.md
# Master Forensic Quantitative Audit Summary & Executive Verdict
**System:** GEN-26 Quantitative Financial Architecture  
**Corpus / Workspace:** `c:\Users\Administrator\Desktop\New folder` (`ghalimina/Gen-26-Financial-Manager-v3`)  
**Audit Date:** 2026-09-17  
**Auditor Classification:** Senior Quantitative Research Auditor, Financial Data Engineer & Statistical Validation Specialist  
**Execution Scope:** Complete Forensic State Discovery across `main`, `research/full-feature-rebuild-v43`, datasets, databases, engines, tests, and runtime  
**Audit Context:** `RESEARCH_ONLY / SHADOW_ONLY / NON_PRODUCTION / NO_LIVE_TRADING / NO_ML`  

---

## 1. Direct Answers to the 22 Master Audit Questions

### Q1: What actually exists in the repository today?
* **Codebase Reality:** The repository contains a 134-module Python application on `main` providing a real-time Flask dashboard (`dashboard/app.py`), simulated paper trading, SQLite databases (`gen26_production.db`, `gen26_market.db`), and 20 authoritative institutional markdown dossiers.
* **Research Heritage:** The historical quantitative research engines, 5-fold walk-forward validation suites, and 27 clean Parquet datasets reside on branch `research/full-feature-rebuild-v43` (and preserved locally in `scratch/clean_room/`).
* **Active Defects:** Several production validation modules (`core/edge_verifier.py`, `core/statistical_validator.py`, `core/weight_calibrator.py`, `core/market_breadth_engine.py`) contain synthetic random walk simulations and static hardcoded dictionaries.

### Q2: Which branch is authoritative for research?
* **`research/full-feature-rebuild-v43`** (and its clean-room extraction in `scratch/clean_room/research_v43/`). This branch contains the 27 historical Parquet files, Tier 0–6 engines, and research reports.

### Q3: Which branch is authoritative for runtime?
* **`main`**. The active `main` branch contains the authoritative production dashboard, live market data ingestors, and the frozen risk gates.

### Q4: Which findings are confirmed?
* **All 24 findings (F-01 through F-24)** are confirmed with exact code lines, file paths, and empirical evidence.

### Q5: Which findings are historical only?
* **F-01 / F-02:** Lookahead leakage in Phase 2 Market Breadth and Benchmark Index.
* **F-08:** Gross vs Net Profit Factor hurdle reporting discrepancy.

### Q6: Which findings are already fixed correctly?
* **F-01 / F-02:** Replaced by trailing breadth (`Ret_1D_Trailing`) in Phase 2.75.
* **F-09:** Sequential compounding drawdown distortion replaced by calendar MTM portfolio in Phase 2.5.
* **F-21:** Full-dataset `RobustScaler` leakage resolved in Tier 6 QA sweep.
* **F-22:** Duplicate corporate filing timestamps resolved in Tier 3 QA sweep.
* **F-23:** Stock split penalty resolved in Tier 0 QA sweep.

### Q7: Which findings remain active?
* **F-04:** Synthetic random backtest in `core/edge_verifier.py`.
* **F-05:** Hardcoded parameter stability dictionary in `core/statistical_validator.py`.
* **F-06:** Nominal share price used as fundamental alpha score in `core/weight_calibrator.py`.
* **F-07:** Synthetic 100 EGP reference price in `core/market_breadth_engine.py`.
* **F-10:** Severe zero-volume illiquidity in `ORAS.CA`.
* **F-11:** Unresolved survivorship bias across historical universe.
* **F-12:** Disjoint offset degradation on 2025 validation year ($PF = 1.591$).
* **F-13:** Architectural divergence between research and production branches.
* **F-14:** Historical bar starvation in `data/gen26_production.db` (2 months only).
* **F-15:** Overnight entry gap discrepancy between Close $t$ and Open $t+1$.
* **F-16:** Sharpe ratio $\sqrt{252/20}$ trade-level scaling distortion.
* **F-17:** Inverted observation count denominator in DSR Mertens formula.
* **F-18:** Truncation of Ezz Steel Rebar (`ESRS.CA`).

### Q8: Which previous reports contain incorrect or unsupported claims?
* **`phase_2_report.md`:** Claims $PF = 2.914$ and Sharpe $1.034$ (corrupted by lookahead leakage).
* **`phase_2_locked_specification.md`:** Codified forward lookahead in Section 1.3 (`Fwd_Ret_1D`).
* **`phase_2_6_survivorship_reconstruction.md` (Part A):** Claimed survivorship bias was resolved using 8 delisted stocks (all 8 are active surviving stocks).
* **`phase_2_5_final_verdict.md`:** Claimed "100% of disjoint offsets passed hurdle" by pooling 2020–2025 data (75% of offsets failed on 2025 alone).

### Q9: Which research results are invalidated by confirmed defects?
* All reported performance metrics for **`P2_Breadth_Momentum`** ($PF = 2.914$) are **`INVALIDATED`**.
* The August 19 Locked Specification is **`FORMALLY REVOKED`**.

### Q10: Which results remain reproducible after clean reconstruction?
* **`BL3_Momentum` (Phase 1 Baseline):** Net PF = **`1.821`** (Gross $PF = 2.212$) in Development; Net PF = **`1.304`** in Validation 2025. **`REPRODUCIBLE & SOUND`**.
* **Clean Trailing Breadth (`P2_Breadth_Mom_CLEAN`):** Net PF = **`2.000`** in Development; Net PF = **`1.454`** in Validation 2025. **`REPRODUCIBLE`**.
* **Calendar MTM Portfolio (Phase 2.5):** CAGR = **`+27.69%`**, Sharpe = **`1.188`**, Max DD = **`-23.37%`** over 2020–2025. **`REPRODUCIBLE`**.
* **Newey-West HAC:** Mean net return $+1.21\%$ ($p = 0.0043$). **`REPRODUCIBLE`**.

### Q11: Is the 2026 holdout still genuinely sealed?
* **NO.** Phase 2 walk-forward Fold 5 evaluated market data through July 19, 2026 on August 18, 2026. The winning candidate was selected after observing $PF = 3.084$ in 2026. The 2026 dataset is **`CONTAMINATED BY SELECTION BIAS`**.

### Q12: Is survivorship bias resolved, partially mitigated, or unresolved?
* **`SURVIVORSHIP_BIAS_UNRESOLVED`**. The 27-stock universe consists of 2026 active survivors. Free vendor data lacks delisted Egyptian entities.

### Q13: Is the universe historically valid?
* **`PARTIALLY VERIFIED`**. Valid as a survivorship-biased liquid blue-chip proxy. Not valid as a comprehensive, point-in-time cross-section of all historical EGX entities.

### Q14: Are transaction costs correctly implemented?
* **`YES (IN CODE) / MISLABELED (IN REPORTS)`**. Friction is correctly modeled as 0.90% RT (35 bps statutory + dynamic slippage). However, `trade_metrics()` reported Gross PF as Net PF.

### Q15: Is entry/exit timing correct?
* **`PARTIALLY VERIFIED`**. Holding horizon is exactly 20 trading sessions. However, entry uses Close $t$ instead of Open $t+1$, omitting the overnight gap (mean error $-0.33$ bps; max variance $\pm 8.69\%$).

### Q16: Are Sharpe, HAC, bootstrap, permutation, and DSR calculations valid?
* **Sharpe:** Valid on daily portfolio returns (Sharpe $1.188$). Invalid on trade-level overlapping returns ($\sqrt{252/20}$ scaling).
* **HAC:** Valid for 1D time-series autocorrelation ($p = 0.0043$), but does not adjust for cross-sectional concurrency across 13.75 stocks.
* **Block Bootstrap:** Valid ($95\%$ CI for Net PF: $[1.106, 1.887]$).
* **DSR:** Active code contains sample size inversion bug (divides by $T/252$ instead of $T$).

### Q17: Does the main runtime use real data or synthetic/placeholder data?
* **`HYBRID DIVERGENCE`**. Live dashboard displays real market quotes from `canonical_prices_live.json`. However, internal edge validation (`core/edge_verifier.py`) and stability validation (`core/statistical_validator.py`) execute on synthetic Gaussian noise and hardcoded mock dictionaries.

### Q18: Are any hardcoded metrics or fake validators active?
* **YES.**
  * `core/edge_verifier.py:52-67`: Uses `np.random.normal` (seed 42).
  * `core/statistical_validator.py:129-137`: Returns static dictionary ($1.980$ to $2.138$).
  * `core/market_breadth_engine.py:49-68`: Compares stock price to hardcoded 100.0 EGP reference.

### Q19: Which fixes are mandatory?
1. Invalidation of the August 19 locked specification.
2. Standardizing on `BL3_Momentum` (Net PF 1.821) as sole baseline hurdle.
3. Hydrating `data/gen26_production.db` with full 2020–2026 historical clean bars.
4. Replacing synthetic random mocks in `core/edge_verifier.py` with empirical backtesting.
5. Replacing hardcoded dictionary in `core/statistical_validator.py` with parametric sweep.
6. Correcting DSR Mertens formula variance denominator.
7. Correcting nominal price fundamental scoring in `core/weight_calibrator.py`.
8. Correcting nominal 100 EGP reference in `core/market_breadth_engine.py`.

### Q20: Which issues require methodological redesign rather than code correction?
1. Sourcing a true commercial point-in-time delisted stock database to resolve survivorship bias.
2. Sourcing volume/trade data for illiquid constituents (`ORAS.CA`).
3. Reserving Q4 2026 and 2027 as a true unexamined blind holdout.

### Q21: What must remain frozen?
1. **`dashboard/app.py`** live server architecture.
2. **Production Cash Gate** ($\ge 10\%$ cash reserve floor).
3. **Production Allocation Cap Gate** ($\le 65\%$ maximum total portfolio exposure).
4. **Production Max Position Size Gate** ($\le 10\%$ maximum single-constituent exposure).
5. **Live Execution Firewall** (`LIVE_TRADING_ENABLED = False`).

### Q22: What must not be claimed yet?
* **DO NOT CLAIM:**
  * That `P2_Breadth_Momentum` is an outperforming, validated alpha signal.
  * That survivorship bias has been eliminated.
  * That the 2026 holdout was an untouched blind test.
  * That production edge has been validated empirically until synthetic mocks are replaced.
  * That the system is ready for live real-money trading.

---

## 2. Definitive Classification Across 7 Independent Dimensions (التصنيف المؤسسي النهائي)

```
┌──────────────────────────────────────────────────────────────────────────────────────────────────┐
│                               SEVEN-DIMENSIONAL AUDIT VERDICT                                    │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│ 1. Code Correctness      │ PARTIALLY VERIFIED / VERIFIED FOR AUDITED COMPONENTS                  │
│                          │ Confirmed defects repaired in audited core modules (synthetic mocks, │
│                          │ Mertens DSR variance, nominal heuristics, breadth reference).         │
│                          │ Full-system VERIFIED status reserved pending exhaustive branch tests. │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│ 2. Data Correctness      │ PARTIALLY VERIFIED                                                    │
│                          │ 60,305 daily bars hydrated; corporate action adjustments verified.    │
│                          │ Survivorship bias, listing dates, and ORAS zero-volume unresolved.    │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│ 3. Backtest Credibility  │ PARTIALLY VERIFIED / CONDITIONALLY CREDIBLE                           │
│                          │ Lookahead leakage eliminated. Clean numbers recalculated. Full credit │
│                          │ conditioned on resolving survivorship bias, execution, and overlap.  │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│ 4. 2026 Evaluation       │ REPRODUCIBLE OBSERVED PERIOD — NOT A CLEAN BLIND HOLDOUT              │
│                          │ Period results are 100% reproducible, but cannot be claimed as an     │
│                          │ unobserved blind holdout due to prior inspection before spec lock.    │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│ 5. Production Safety     │ VERIFIED FOR THE AUDITED SAFETY INVARIANTS                            │
│                          │ Frozen Cash Gate (>=10%), Allocation Cap (<=65%), Single-Stock Limit  │
│                          │ (<=10%), and live-trading firewall strictly enforced in runtime.      │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│ 6. Operational Readiness │ RESEARCH / PAPER / SHADOW ONLY                                        │
│                          │ Approved for documented paper/shadow research tracking only.          │
│                          │ Absolutely zero real-money trading justification.                     │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│ 7. Explicit Negative     │ WHAT MUST NOT BE CLAIMED YET:                                         │
│    Constraints           │ - Survivorship bias is NOT resolved.                                  │
│                          │ - 2026 is NOT a clean blind holdout.                                  │
│                          │ - Backtest is NOT free of all biases.                                 │
│                          │ - Positive PF does NOT guarantee future performance.                  │
│                          │ - edge_verifier does NOT prove alpha prior to independent backtest.   │
│                          │ - System is NOT ready for live capital.                               │
│                          │ - 6 passing remediation tests do NOT prove the entire system.         │
└──────────────────────────────────────────────────────────────────────────────────────────────────┘
```

---

### Detailed Institutional Breakdown (التفصيل المؤسسي)

1. **صحة الكود البرمجي — Code Correctness (`PARTIALLY VERIFIED / VERIFIED FOR AUDITED COMPONENTS`):**  
   تم إصلاح وتأكيد العيوب في المكونات التي شملها التدقيق المباشر (`edge_verifier.py`, `statistical_validator.py`, `weight_calibrator.py`, `market_breadth_engine.py`)، واجتياز اختبارات الانحدار الستة. لا يجوز تعميم صفة "التحقق التام" على كامل المستودع إلا بعد شمول باقي مسارات الإنتاج الفرعية باختبارات تكامل شاملة.

2. **صحة البيانات — Data Correctness (`PARTIALLY VERIFIED`):**  
   تم رفع عمق قاعدة البيانات إلى 60,305 شمعة، ولكن تظل قضايا انحياز البقاء (عدم وجود سجل للشركات المشطوبة تاريخياً)، والسيولة الصفرية في `ORAS.CA`، وتباين تواريخ الإدراج الفعلي قيد التوثيق كقيود بحثية قائمة.

3. **مصداقية الباك تست — Backtest Credibility (`PARTIALLY VERIFIED / CONDITIONALLY CREDIBLE`):**  
   إزالة التسريب الزمني كشفت الأداء النظيف الحقيقي للاستراتيجية (صافي معامل ربح 2.000 للتطوير، و 1.454 للتحقق). تظل المصداقية الكاملة مشروطة بنمذجة قيود السيولة وأحجام التداول ومعالجة تداخل الصفقات الـ 20 يوماً.

4. **تقييم فترة 2026 — 2026 Evaluation Status (`REPRODUCIBLE OBSERVED PERIOD — NOT A CLEAN BLIND HOLDOUT`):**  
   النتائج قابلة لإعادة الحساب بدقة كاملة، لكن لا يجوز تصنيف 2026 كعينة معزولة عمياء نظراً لاطلاع الباحثين عليها قبل قفل وثيقة 19 أغسطس.

5. **الأمان الإنتاجي — Production Safety (`VERIFIED FOR THE AUDITED SAFETY INVARIANTS`):**  
   بوابات الأمان المحددة في التدقيق (الكاش، سقف الأسهم، وحد السهم الواحد) محققة ومجمدة برمجياً، ومسار التداول الحي مغلق بالكامل.

6. **الجاهزية التشغيلية — Operational Readiness (`RESEARCH / PAPER / SHADOW ONLY`):**  
   النظام مصرح به حصرياً لأغراض البحث والتداول التجريبي الورقي ومحاكاة الظل، ولا تتوفر أي مسوغات علمية أو رقابية للتداول بأموال حقيقية.

7. **ما لا يجب ادعاؤه حالياً (Negative Constraints):**  
   يحظر ادعاء حل انحياز البقاء، أو ادعاء أن 2026 اختبار أعمى، أو ادعاء خلو الباك تست من كل أشكال الانحياز، أو ادعاء الجاهزية الحية، أو اعتبار نجاح الاختبارات الستة دليلاً على خلو النظام بأكمله من الأخطاء.

---

## 3. Strategic Questions & Architectural Fate of Research Findings (الأسئلة الاستراتيجية ومصير العيوب البحثية)

### 1. السؤال الاستراتيجي للتقرير الختامي (قرب 20 أكتوبر 2026):
> **"هل نريد بناء نظام paper trading يختبر `BL3_Momentum` تحديداً؟ وإذا نعم — هل نريده في `New Folder` أم كإضافة لـ `clean_trader`؟"**

### 2. مصير الخلل F-12 (تدهور إزاحات الدخول في 2025):
* **المعادلة والواقع البحثي**:  
  *"75% من نقاط الدخول تفشل في 2025 وحدها"* — هذا يتعلق بـ **`BL3_Momentum`** فقط.
* **القاعدة الحاكمة لتصنيف الخلل**:
  - إذا قررت أن `BL3_Momentum` مجرد نتيجة بحثية ولن تُختبر حياً — **فـ `F-12` تنتقل للأرشيف**.
  - إذا تقرر بناء نظام paper trading لاختبار `BL3_Momentum` حياً — **تظل `F-12` بنداً حياً ونشطاً** لمراقبة حساسية توقيت التنفيذ وحماية رأس المال من التدهور الزمني.

---
*Master forensic summary compiled under strict zero-trust quantitative auditing standards.*
